VYNE Therapeutics to Participate in March Investor Conferences

Company Overview - VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies for chronic inflammatory and immune-mediated conditions with high unmet need [3]. Upcoming Investor Conferences - VYNE's management will participate in two investor conferences in March 2025: - TD Cowen 45th Annual Health Care Conference in Boston, MA on March 4, 2025, featuring a fireside chat and one-on-one meetings [1]. - Leerink Partners Global Healthcare Conference in Miami, FL on March 11, 2025, consisting of one-on-one meetings [2]. Product Development - VYNE's proprietary BET inhibitors, part of its InhiBET™ platform, aim to address limitations of early generation BET inhibitors by utilizing alternative routes of administration and enhanced selectivity [3].